Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-13Clinical Trial Update: 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer [Phase 2]
Phase 2 trial evaluating 18F-PSMA PET/MRI for diagnosing clinically significant prostate cancer has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer [Phase 1]
A Phase 1 trial evaluating autologous T cells engineered to express L1CAM-specific CARs for locally advanced, unresectable, or metastatic sm…
-
CLINICAL_TRIALS withdrawal · 2025-03-12Clinical Trial Update: Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone
Clinical trial update reports real-world Brazilian experience in castration-resistant prostate cancer patients treated with the combination …
-
CLINICAL_TRIALS withdrawal · 2025-03-10Clinical Trial Update: Single-Port Versus Multi-Port Robotic Radical Prostatectomy [NA]
A clinical trial evaluating single-port versus multi-port robotic radical prostatectomy for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-25Clinical Trial Update: Study of rSIFN-co for Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of rSIFN-co for advanced solid tumors has been terminated, involving malignancies including melanoma, kidney cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: PRISMA-PET - Primary Staging of Prostate Cancer With PSMA [NA]
The PRISMA-PET trial for primary staging of prostate cancer using PSMA imaging has been terminated. Sponsor Odense University Hospital.
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
A clinical trial registry entry for Janssen's prospective compliance registry in metastatic castration-resistant prostate cancer has been wi…
-
CLINICAL_TRIALS withdrawal · 2025-01-08Clinical Trial Update: Dynamic Whole Body PET/ MRI
A clinical trial studying dynamic whole-body PET/MRI for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-03Clinical Trial Update: Prostate MRI and Pylarify PSMA PET/CT [Phase 4]
A Phase 4 clinical trial evaluating prostate MRI and Pylarify PSMA PET/CT for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-10Clinical Trial Update: The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
The clinical trial evaluating the predictive value of TMPRSS2-ERG fusion in high-risk prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-10Clinical Trial Update: Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
This clinical trial investigated DNA changes in high-risk prostate cancer to determine prognosis, but the study status is withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-18Clinical Trial Update: Multi-target Tracking in Prostate Radiotherapy Using MLC and KIM [NA]
The clinical trial NCT02588846 evaluating multi-target tracking in prostate radiotherapy using MLC and KIM has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer [Phase 1, Phase 2]
A clinical trial evaluating Copanlisib in combination with Degarelix for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer
This trial evaluating real-life use of a leuprorelin 5 mg implant in prostate cancer patients has been withdrawn. No results were reported.
-
CLINICAL_TRIALS withdrawal · 2024-10-08Clinical Trial Update: Using Meditation for Oncology Anxiety [NA]
Clinical trial evaluating meditation for oncology-related anxiety has been withdrawn. The listed conditions include anxiety, quality of life…
-
CLINICAL_TRIALS withdrawal · 2024-10-04Clinical Trial Update: Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome [Phase 3]
A Phase 3 trial evaluating metformin for prevention and intervention of metabolic syndrome in patients initiating androgen deprivation thera…
-
CLINICAL_TRIALS withdrawal · 2024-09-25Clinical Trial Update: 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study [EARLY_Phase 1]
An EARLY Phase 1 pilot study evaluating the 18F-rhPSMA-7.3 PET/MRI tracer for prostate cancer under active surveillance has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors [NA]
A clinical trial evaluating race-specific AGE accumulation as a behavioral biomarker in prostate cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: A Yoga Program for Patients Undergoing Prostate Cancer Surgery [NA]
A VA-sponsored clinical trial evaluating a yoga program for patients undergoing prostate cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating 177Lu-PSMA-617 with Niraparib and abiraterone acetate plus prednisone for metastatic prostate cancer and castra…
-
CLINICAL_TRIALS withdrawal · 2024-08-19Clinical Trial Update: HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) [Phase 3]
Phase 3 trial HC-1119 versus enzalutamide for metastatic castration-resistant prostate cancer has been terminated; no results are provided i…
-
CLINICAL_TRIALS withdrawal · 2024-08-13Clinical Trial Update: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating TNG348 alone and in combination with a PARP inhibitor for BRCA1/2-mutant or HRD-positive solid tumors has been …
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy [NA]
A clinical trial evaluating prostatic artery embolization for lower urinary tract symptoms in prostate cancer patients undergoing radiation …
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: Neoadjuvant Listeria or Daratumumab in Prostate Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating Listeria-based immunotherapy versus Daratumumab in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-14Clinical Trial Update: Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC [Phase 3]
Phase 3 trial investigating darolutamide with radium-223 or placebo in metastatic castration-resistant prostate cancer was withdrawn.